Thermo Fisher Scientific (TMO) Confirms Offer to Acquire QIAGEN (QGEN) Shares Expires on August 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
UPDATE: Qiagen (QGEN) Tops Q2 EPS by 9c, Revenues Beat; Boards Reaffirms Unanimous Recommendation Shareholders Accept Thermo Fisher (TMO) Offer
August 4, 2020 4:21 PM EDT(Updated - August 4, 2020 4:22 PM EDT)
Qiagen (NYSE: QGEN) reported Q2 EPS of $0.55, $0.09 better than the analyst estimate of $0.46. Revenue for the quarter came in at $443.3 million versus the consensus estimate of $425.82 million.
Q2 2020 results:Net sales of $443.3 million (+16% actual, +19% CER)Diluted EPS $0.38; adjusted EPS $0.55 ($0.56 CER, +70% CER)H1 2020 results:Net sales of $815.3 million (+12% actual, +14% CER)Diluted EPS $0.56; adjusted EPS $0.89 ($0.90 CER, +50% CER)QIAGEN Boards have reaffirmed unanimous recommendation that QIAGEN... More